Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yunsheng Yanxin Biotechnology is a specialized biotechnology firm based in Shanghai, China, focusing on pharmaceutical R&D and advanced drug delivery technologies. Founded in 2012 and headquartered in the Zhangjiang High Tech Park, the company provides a range of technical services including formulation development, process chemistry, and drug delivery system innovation. It is closely associated with the Bozhi Yanxin (Bozhimed) group, a prominent contract research organization (CRO) and contract development and manufacturing organization (CDMO) in the region. The company's expertise is reflected in its extensive patent portfolio covering small molecule therapeutics for gastrointestinal, metabolic, and oncological indications. Yunsheng Yanxin aims to enhance the therapeutic profile of existing and novel drugs through sophisticated formulation and manufacturing solutions for global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai YunSheng YanXin Biotechnology.